Guia de Prà ctica Clínica sobre el tractament de la dependència de ...

REFERÈNCIES BIBLIOGRÀFIQUESLynch KG, Suh JJ, Dackis CA, Oslin DW, O’Brien CP. Gender differences with high-dose naltrexonein patients with co-occurring cocaine and alcohol dependence. J Subst Abuse Treat 2008; 34 (4):378-90.Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment ofsubstance use disorders: a meta-analysis. Addiction 2006; 101 (11): 1546-60.Poling J, Oliveto A, Petry N, Sofuoglu M, Gonsai K, Gonzalez G, Martell B, Kosten TR. Six-monthtrial of bupropion with contingency management for cocaine dependence in a methadone-maintainedpopulation. Arch Gen Psychiatry 2006; 63 (2): 219-28.Rapp RC, Siegal HA, Li L, Saha P. Predicting postprimary treatment services and drug use outcome:a multivariate analysis. Am J Drug Alcohol Abuse 1998; 24 (4): 603-15.Rawson RA, Huber A, McCann M, Shoptaw S, Farabee D, Reiber C, Ling W. A comparison ofcontingency management and cognitive-behavioral approaches during methadone maintenancetreatment for cocaine dependence. Arch Gen Psychiatry 2002; 59 (9): 817-24.Rawson RA, McCann MJ, Flammino F, Shoptaw S, Miotto K, Reiber C, Ling W. A comparison ofcontingency management and cognitive-behavioral approaches for stimulant-dependent individuals.Addiction 2006; 101 (2): 267-74.Reid MS, Casadonte P, Baker S, Sanfilippo M, Braunstein D, Hitzemann R, et al. A placebo-controlledscreening trial of olanzapine, valproate and coenzyme Q10/L-carnitine for the treatment ofcocaine dependence. Addiction 2005; 100 (supl. 1): 43-57.Rhodes W, Gross M. Case management reduces drug use and criminality among drug-involvedarrestees: An experimental evaluation of and HIV prevention intervention. Washington DC: NationalInstitute of Justice, 1997.Richard AJ, Montoya ID, Nelson R, Spence RT: Effectiveness of adjunct therapies in crack cocainetreatment. J Subst Abuse Treat 1995; 12: 401-13.Ritter A, Cameron J. A review of the efficacy and effectiveness of harm reduction strategies foralcohol, tobacco and illicit drugs. Drug Alcohol Rev 2006; 25 (6): 611-24.Rohsenow DJ, Monti PM, Martin RA, Colby SM, Myers MG, Gulliver SB, Brown RA, Mueller TI,Gordon A, Abrams DB. Motivational enhancement and coping skills training for cocaine abusers:effects on substance use outcomes. Addiction 2004; 99 (7): 862-74.Roncero C, Casas M. Problemas relacionados con el abuso de sustancias A: Vázquez-BarqueroJ.L. Psiquiatría y atención primaria. Aula Médica. Madrid, 2007: 441-53.Roozen HG, Boulogne JJ, van Tulder MW, van den Brink W, De Jong CA, Kerkhof AJ. A systematicreview of the effectiveness of the community reinforcement approach in alcohol, cocaine andopioid addiction. Drug Alcohol Depend 2004; 74 (1): 1-13.Rubio G, Martínez I, Ponce G, Jiménez-Arriero MA, López-Muñoz F, Alamo C. Long-acting injectablerisperidone compared with zuclopenthixol in the treatment of schizophrenia with substanceabuse comorbidity. Can J Psychiatry 2006 Jul; 51 (8): 531-9.Sacks S, Sacks JY, McKendrick K, Banks S, Stommel J. Modified TC for MICA offenders: Crimeoutcomes. Behavioral Sciences and the Law 2004;22(4):477–501.San L, Arranz B, Martinez-Raga J. Antipsychotic drug treatment of schizophrenic patients withsubstance abuse disorders. Eur Addict Res 2007; 13 (4): 230-43.Sánchez-Niubò A, Domingo-Salvany A, Melis GG, Brugal MT, Scalia-Tomba G. Dos métodos paraanalizar la evolución de la incidencia de consumo de heroína y cocaína en Barcelona. Gac Sanit2007; 21 (5): 397-403.243 Guia de Pràctica Clínica de la cocaïna